Clin2
NCT07740317Possibly a fitNot yet recruiting

Thinking and memory after car-t therapy for multiple myeloma

Multiple Myeloma (MM)CART TherapyRefractory Multiple Myeloma (RRMM)

Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.

This study looks at how car-t therapy affects thinking and memory over time. If you have multiple myeloma and are getting this treatment, you may be able to help learn what to expect.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Observational

Who can take part

  • Be 18 years or older
  • Have been scheduled to receive car-t therapy for your multiple myeloma
  • Be able to read and understand english
  • Be able to come to clinic visits or have internet for online sessions
  • Be in good enough health to participate (doctor's ok)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07342179Recruiting
Monitoring immune cells after CAR-T therapy for myeloma

This study looks at how your immune system responds after you receive CAR-T cell therapy for multiple myeloma. The goal is to learn more about the treatment's effects and how well it works.

Poitiers
NCT07609030Recruiting
Brain Training During CAR-T Cell Cancer Treatment

This study tests whether special brain exercises can help protect thinking and memory skills during CAR-T cell therapy—a newer cancer treatment for certain blood cancers. Researchers want to see if training your brain during treatment reduces side effects on memory and mental function.

Columbus, Ohio
NCT07463781Not yet recruiting
Thinking and memory in CAR-T cell therapy for lymphoma

This study looks at how CAR-T cell therapy for certain types of lymphoma may affect thinking and memory. It helps doctors understand and support patients' brain health during treatment.

Alessandria
NCT06971380Recruiting· Phase 2
CAR-T therapy for multiple myeloma and amyloidosis

This trial tests a new CAR-T cell treatment (HBI0101) for people with multiple myeloma or light-chain amyloidosis that has come back or stopped responding to other treatments. The therapy uses your own immune cells to fight cancer, and the goal is to see if it can help control the disease.

Jerusalem
NCT07689058Recruiting· Phase 2
CAR-T therapy for relapsed or refractory multiple myeloma

This trial tests a CAR-T cell therapy for multiple myeloma that has come back or not responded to at least three prior treatments. It aims to see if this immunotherapy can help control the disease.

Rawalpindi, Punjab Province
NCT07375628Not yet recruiting
Brain and thinking changes after CAR-T therapy

This trial looks at how CAR-T treatment affects the brain and thinking skills. It aims to better understand and help with side effects like confusion or memory problems.

Hear when a new CART Therapy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.